You just read:

Jazz Pharmaceuticals Announces Completion of Offering and Exercise in Full of Initial Purchasers' Option to Purchase Additional 1.50% Exchangeable Senior Notes due 2024

News provided by

Jazz Pharmaceuticals plc

01 Sep, 2017, 17:45 BST